Y Takimoto

461 total citations
48 papers, 355 citations indexed

About

Y Takimoto is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Y Takimoto has authored 48 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Y Takimoto's work include Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Y Takimoto is often cited by papers focused on Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Y Takimoto collaborates with scholars based in Japan, Greece and United Kingdom. Y Takimoto's co-authors include Atsushi Kuramoto, Thomas F. Deuel, Akiro Kimura, Akira Sakai, Hideki Asaoku, Yuta Katayama, Naomi Sasaki, Nobuo Oguma, Hideo Tanaka and Kôji Nanba and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.

In The Last Decade

Y Takimoto

47 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Takimoto Japan 11 157 97 68 53 52 48 355
K Hayashi Japan 11 93 0.6× 92 0.9× 72 1.1× 66 1.2× 42 0.8× 24 371
Sophie Kaltenbach France 10 237 1.5× 99 1.0× 71 1.0× 75 1.4× 44 0.8× 21 421
Catia Lo Pardo Italy 14 266 1.7× 242 2.5× 78 1.1× 60 1.1× 45 0.9× 18 507
Frank El Ouriaghli United States 9 133 0.8× 67 0.7× 126 1.9× 36 0.7× 34 0.7× 10 390
Shigefumi Hayashi Japan 12 212 1.4× 153 1.6× 57 0.8× 27 0.5× 27 0.5× 16 506
Cassandra P. Loren United States 7 111 0.7× 196 2.0× 50 0.7× 27 0.5× 36 0.7× 8 342
Rosalia de Necochea-Campion United States 14 240 1.5× 48 0.5× 90 1.3× 27 0.5× 56 1.1× 22 451
Björn Jacobsson Sweden 11 158 1.0× 214 2.2× 73 1.1× 45 0.8× 13 0.3× 14 471
Derya Aslan Denmark 11 183 1.2× 34 0.4× 56 0.8× 41 0.8× 25 0.5× 13 354
P. A. Bernabei Italy 8 162 1.0× 70 0.7× 71 1.0× 15 0.3× 22 0.4× 20 328

Countries citing papers authored by Y Takimoto

Since Specialization
Citations

This map shows the geographic impact of Y Takimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Takimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Takimoto more than expected).

Fields of papers citing papers by Y Takimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Takimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Takimoto. The network helps show where Y Takimoto may publish in the future.

Co-authorship network of co-authors of Y Takimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Y Takimoto. A scholar is included among the top collaborators of Y Takimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Takimoto. Y Takimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hama, Seiji, Hidehisa Yamashita, Atsuko Watanabe, et al.. (2007). Sitting balance as an early predictor of functional improvement in association with depressive symptoms in stroke patients. Psychiatry and Clinical Neurosciences. 61(5). 543–551. 30 indexed citations
3.
Kuroda, Yoshiaki, Akira Sakai, Yuta Katayama, et al.. (2005). The Maturation of Myeloma Cells Correlates with Sensitivity to Chemotherapeutic Agents. International Journal of Hematology. 81(4). 335–341. 8 indexed citations
4.
Shoda, Tomoko, et al.. (2004). [Chronic myelogenous leukemia following therapy for pineal germinoma].. PubMed. 45(1). 72–4. 2 indexed citations
5.
Sakai, Akira, Y Takimoto, Jun Imagawa, et al.. (2004). Progressive Myeloma after Thalidomide Therapy in a Patient with Immature Phenotype of Myeloma (Plasma) Cells. International Journal of Hematology. 79(4). 364–368. 3 indexed citations
6.
Katayama, Yuta, Akira Sakai, Naohide Oue, et al.. (2003). A possible role for the loss of CD27–CD70 interaction in myelomagenesis. British Journal of Haematology. 120(2). 223–234. 28 indexed citations
7.
Ishida, Hideharu, Toshio Yoshida, Kyoko Okada, & Y Takimoto. (2003). Laparoscopic Radical Retropubic Prostatectomy Combined with Approaches through a Small Open Incision. Aktuelle Urologie. 34(4). 231–233.
8.
Kuramoto, Ken, Akira Sakai, Kazushi Shigemasa, et al.. (2002). High expression of MCL1 gene related to vascular endothelial growth factor is associated with poor outcome 
in non‐Hodgkin's lymphoma. British Journal of Haematology. 116(1). 158–161. 28 indexed citations
9.
Takimoto, Y, et al.. (1999). Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma.. PubMed. 70(2). 127–31. 8 indexed citations
10.
Takimoto, Y, et al.. (1997). Transcription Regulation of the PDGF A-Chain Gene by First Intron Elements. Biochemical and Biophysical Research Communications. 230(3). 569–572. 11 indexed citations
11.
Takimoto, Y, et al.. (1996). Anaplastic Large-Cell Lymphoma (KM Lymphoma) with Expression of IL-5 mRIMA and Eosinophilic Invasion. Acta Haematologica. 96(4). 245–248. 10 indexed citations
12.
Kawata, Naoko, et al.. (1996). [Immunological effect of recombinant interferon-gamma on tumor infiltrating lymphocytes of renal cell carcinoma--relationship with clinical stage].. PubMed. 42(1). 1–4. 5 indexed citations
13.
Takimoto, Y & Atsushi Kuramoto. (1995). Mechanism of regulation of PDGF-A chain gene expression by serum and TPA. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1260(2). 176–182. 5 indexed citations
14.
Takimoto, Y & Atsushi Kuramoto. (1994). Gene regulation by the 5′-untranslated region of the platelet-derived growth factor A-chain. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1222(3). 511–514. 8 indexed citations
15.
Takimoto, Y, et al.. (1994). Hodgkin’s Disease Associated with Chronic Myeloid Leukemia. Acta Haematologica. 92(2). 97–100. 1 indexed citations
16.
Kawata, Naoko, et al.. (1994). [Clinical trial of inhalant recombinant interferon-gamma in patients with pulmonary metastasis from renal tumor (preliminary report)].. PubMed. 40(9). 773–6. 1 indexed citations
17.
Takimoto, Y & Atsushi Kuramoto. (1993). Presence of a Regulatory Element within the First Intron of the Human Platelet‐derived Growth Factor‐A Chain Gene. Japanese Journal of Cancer Research. 84(12). 1268–1272. 8 indexed citations
18.
Kuroi, Katsumasa, Akihiko Osaki, Masakazu Toi, et al.. (1993). Primary squamous cell carcinoma of the breast after cured Hodgkin's disease. Surgery Today. 23(1). 81–84. 3 indexed citations
19.
Takimoto, Y, et al.. (1991). Promoter region of the human platelet-derived growth factor A-chain gene.. Proceedings of the National Academy of Sciences. 88(5). 1686–1690. 50 indexed citations
20.
Takimoto, Y, et al.. (1989). [Investigation of intracavernous injection of papaverine for erectile impotence].. PubMed. 35(1). 71–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026